Subacute Cutaneous Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Subacute Cutaneous Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus [Phase 2, Phase 3]
Biogen is conducting a two-part Phase 2/3 trial evaluating litifilimab (BIIB059) for adults with active cutaneous lupus erythematosus; the s…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) [Phase 2]
A Phase 2 clinical trial evaluating safety, tolerability, and efficacy of IMVT-1402 in adults with subacute and chronic cutaneous lupus eryt…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus [Phase 3]
This clinical trial update describes a long-term extension study evaluating the safety of Litifilimab (BIIB059) injections and its potential…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus [Phase 3]
A Phase 3 trial evaluating anifrolumab for chronic and/or subacute cutaneous lupus erythematosus is currently recruiting.